Stefan Keveloh
Nessuna posizione attualmente
Profilo
Stefan Keveloh, who worked at Avontec GmbH as Director-Supervisory Board and at Sparkasse Göttingen as Principal, has a career history in business and finance.
Precedenti posizioni note di Stefan Keveloh
| Società | Posizione | Fine |
|---|---|---|
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Direttore/Membro del Consiglio | 16/06/2010 |
Sparkasse Göttingen
 Sparkasse Göttingen Savings BanksFinance Part of Deutscher Sparkassen-und Giroverband eV, Sparkasse Göttingen is a financial institution based in Göttingen, Germany. Sparkasse Göttingen provides online banking services and a range of financial products and services for both private and corporate customers. The CEO of the German company is Rainer Hald. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Health Technology |
Sparkasse Göttingen
Sparkasse Göttingen Savings BanksFinance Part of Deutscher Sparkassen-und Giroverband eV, Sparkasse Göttingen is a financial institution based in Göttingen, Germany. Sparkasse Göttingen provides online banking services and a range of financial products and services for both private and corporate customers. The CEO of the German company is Rainer Hald. | Finance |
- Borsa valori
- Insiders
- Stefan Keveloh
